Government may suspend sale of banned drugs taking cue from global drug regulators – The Economic Times

30 Apr

See on Scoop.itObamacare

India plans to suspend sale of medicines that are banned in one of the six major global drug markets for harmful side-effects, said two senior government officials.

According to a health ministry official, if a drug is banned by the US, UK, Canada, Japan, European Union or Australia, its sales will be stopped in India until clinical data proves that it will not have adverse effect on patients in the country. These embargoes will be triggered by future action of international regulators, and will not automatically apply to drugs that have already been banned in the developed countries.

Drug Controller General of India GN Singh confirmed such a move was on the anvil. “We are in the process of streamlining a mechanism through which our drug regulatory system takes an initial cue from the decisions of leading drug regulators globally on banned drugs. These drug regulators already have in place robust systems to generate and analyse volumes of data on adverse drug reactions to reach decision on drug bans,” said Singh.

The proposal to link medicine bans in the country to the verdicts of regulators in developed countries is significant as India at present does not have a sound system in place to filter and shunt drugs that trigger serious side-effects.

See on


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: